IRIS
RENI, MICHELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.201
EU - Europa 1.194
AS - Asia 233
SA - Sud America 8
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 2
Totale 2.645
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.193
SE - Svezia 805
IT - Italia 185
CN - Cina 115
FI - Finlandia 80
SG - Singapore 44
IE - Irlanda 40
DE - Germania 38
IN - India 22
GB - Regno Unito 15
JP - Giappone 15
HK - Hong Kong 13
IR - Iran 10
FR - Francia 8
EU - Europa 7
NL - Olanda 7
CA - Canada 5
BR - Brasile 4
ES - Italia 4
TR - Turchia 4
CH - Svizzera 3
CZ - Repubblica Ceca 3
ID - Indonesia 3
MX - Messico 3
AT - Austria 2
AU - Australia 2
BD - Bangladesh 2
MM - Myanmar 2
MY - Malesia 2
PE - Perù 2
AR - Argentina 1
BE - Belgio 1
CL - Cile 1
IQ - Iraq 1
PL - Polonia 1
RO - Romania 1
RU - Federazione Russa 1
Totale 2.645
Salva come PNG Salva come JPEG
Città #
Lawrence 342
Princeton 342
Ashburn 106
Shanghai 96
Helsinki 77
New York 61
Boardman 56
Milan 55
Dublin 40
Singapore 26
Rome 22
Seattle 12
Tokyo 12
Washington 10
Pune 9
Hong Kong 8
London 8
Hanover 7
Kish 7
Los Angeles 6
Paris 6
Carlsbad 5
Alessandria 4
Brescia 4
Mountain View 4
Mumbai 4
Turin 4
Verona 4
Amsterdam 3
Andover 3
Borås 3
Buffalo 3
Central 3
Durham 3
Hyderabad 3
Jakarta 3
Lappeenranta 3
Mugnano del Cardinale 3
Treviso 3
Winston-Salem 3
Albizzate 2
Arequipa 2
Berlin 2
Castelfranco Emilia 2
Charlotte 2
Chicago 2
Chittagong 2
Colleferro 2
Cuneo 2
Delhi 2
Düsseldorf 2
Egham 2
Ferrara 2
Gainesville 2
George Town 2
Lecco 2
Lucknow 2
Madrid 2
Modena 2
Naaldwijk 2
Naples 2
New Haven 2
Orem 2
Palermo 2
Providence 2
Puebla City 2
Reggio Emilia 2
Rio de Janeiro 2
Rivoli 2
Rockville 2
San Giuseppe Vesuviano 2
San Maurizio Canavese 2
Santa Clara 2
Settimo Milanese 2
São Paulo 2
Toronto 2
Vienna 2
Aalter 1
Alpharetta 1
Arrecifes 1
Bari 1
Bengaluru 1
Birmingham 1
Boston 1
Boulder 1
Brisbane 1
Campodolcino 1
Columbus 1
Conthey 1
Dundee 1
Eccles 1
Evesham 1
Ferentino 1
Fiorano Modenese 1
Florence 1
Flushing 1
Freiburg 1
Geislingen an der Steige 1
Genoa 1
Gurgaon 1
Totale 1.470
Salva come PNG Salva come JPEG
Nome #
Brain metastases in locally advanced nonsmall cell lung carcinoma after multimodality treatment - Risk factors analysis 52
Linee guida AIOM per le neoplasie cerebrali. 47
Necrosis volume and Choi criteria predict the response to endoscopic ultrasonography-guided HybridTherm ablation of locally advanced pancreatic cancer 31
Evolving pancreatic cancer treatment: From diagnosis to healthcare management 31
Quaderni dell’infermiere-Neurologia III edizione 29
A randomized phase II trial of two different 4-drug combinations in advanced pancreatic adenocarcinoma: cisplatin, capecitabine, gemcitabine plus either epirubicin or docetaxel (PEXG or PDXG regimen). 27
Exploring chemotherapy holiday and drugs re-challenge in advanced pancreatic cancer patients 26
A randomised phase 2 trial of nab-paclitaxel plus gemcitabine with or without capecitabine and cisplatin in locally advanced or borderline resectable pancreatic adenocarcinoma 23
COMMUNI.CARE (COMMUNIcation and Patient Engagement at Diagnosis of PAncreatic CAncer): Study Protocol 22
Nab-paclitaxel plus gemcitabine with or without capecitabine and cisplatin in metastatic pancreatic adenocarcinoma (PACT-19): a randomised phase 2 trial 21
Time to CA19-9 nadir: a clue for defining optimal treatment duration in patients with resectable pancreatic ductal adenocarcinoma 20
RNA Extraction from Endoscopic Ultrasound-Acquired Tissue of Pancreatic Cancer Is Feasible and Allows Investigation of Molecular Features 20
EUS-guided GastroEnterostomy for management of malignant Gastric Outlet Obstruction: a prospective cohort study with matched comparison with Enteral Stenting 18
The role of biliary events in treatment and survival of patients with advanced pancreatic ductal adenocarcinoma 18
RANDOMIZED PHASE II TRIAL ON PRIMARY CHEMOTHERAPY (CHT) WITH HIGH-DOSE METHOTREXATE (MTX) ALONE OR ASSOCIATED WITH HIGH-DOSE CYTARABINE (ARAC) FOR PATIENTS (PTS) WITH PRIMARY CNS LYMPHOMA (PCNSL): THE INTERNATIONAL EXTRANODAL LYMPHOMA STUDY GROUP (IELSG) #20 TRIAL 18
Proposal for a New Pathologic Prognostic Index After Neoadjuvant Chemotherapy in Pancreatic Ductal Adenocarcinoma (PINC). 18
A multicenter study of treatment of primary CNS lymphoma 17
ASO Visual Abstract: The Impact of CT-Assessed Liver Steatosis on Postoperative Complications After Pancreaticoduodenectomy for Cancer 16
Guideline Application in Real world: multi-Institutional Based survey of Adjuvant and first-Line pancreatic Ductal adenocarcinoma treatment in Italy. Primary analysis of the GARIBALDI survey 16
A MULTICENTER TRIAL ASSESSING FEASIBILITY AND EFFICACY OF A COMBINATION OF HIGH-DOSE METHOTREXATE, CYTARABINE AND THIOTEPA IN PATIENTS WITH PRIMARY CNS LYMPHOMA: IMPACT ON OUTCOME OF CYTARABINE DOSE 16
Combined treatment with high-dose methotrexate, vincristine and procarbazine, without intrathecal chemotherapy, followed by consolidation radiotherapy for primary central nervous system lymphoma in immunocompetent patients 16
Postoperative Outcomes and Functional Recovery After Preoperative Combination Chemotherapy for Pancreatic Cancer: A Propensity Score-Matched Study 16
Circulating Chromogranin A Is Cleaved Into Vasoregulatory Fragments in Patients With Pancreatic Ductal Adenocarcinoma 16
Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: Results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial 16
Comment on "prognostic Factors of Survival after Neoadjuvant Treatment and Resection for Initially Unresectable Pancreatic Cancer": What Is Good for the Surgeon Is Just as Good for the Patient? 16
XELIRI OR FOLFIRI AS SALVAGE THERAPY IN ADVANCED PANCREATIC CANCER 16
Prognosis of Upfront Surgery for Pancreatic Cancer: A Systematic Review and Meta-Analysis of Prospective Studies 16
Corneal and Epidermal Nerve Quantification in Chemotherapy Induced Peripheral Neuropathy 16
A preclinical evaluation of pemetrexed and irinotecan combination as second-line chemotherapy in pancreatic cancer 15
A preoperative score to predict early death after pancreatic cancer resection 15
Early variation of 18-fluorine-labelled fluorodeoxyglucose PET-derived parameters after chemoradiotherapy as predictors of survival in locally advanced pancreatic carcinoma patients 15
A multicenter study of the prognosis and treatment of adult brain ependymal tumors 15
Exploring the optimal therapeutic management of stage ypIA pancreatic ductal adenocarcinoma patients in the era of primary chemotherapy 14
The impact of nutritional status on pancreatic cancer therapy 14
A comprehensive in vitro characterization of pancreatic ductal carcinoma cell line biological behavior and its correlation with the structural and genetic profile 14
Basophil Recruitment into Tumor-Draining Lymph Nodes Correlates with Th2 Inflammation and Reduced Survival in Pancreatic Cancer Patients 14
New era for pancreatic endoscopic ultrasound: From imaging to molecular pathology of pancreatic cancer 14
An Italian cost-effectiveness analysis of paclitaxel albumin (nab-paclitaxel) + gemcitabine vs gemcitabine alone for metastatic pancreatic cancer patients: the APICE study 14
A systematic review of surgical resection of liver-only synchronous metastases from pancreatic cancer in the era of multiagent chemotherapy 14
Prediction of early distant recurrence in upfront resectable pancreatic adenocarcinoma: A multidisciplinary, machine learning-based approach 14
A RANDOMIZED PHASE II TRIAL OF TWO DIFFERENT FOUR DRUG COMBINATIONS IN ADVANCED PANCREATIC ADENOCARCINOMA: CISPLATIN, CAPECITABINE, GEMCITABINE PLUS EITHER EPIRUBICIN OR DOCETAXEL 14
A MULTICENTER RETROSPECTIVE STUDY OF CHEMOTHERAPY IN ADULTS WITH EPENDYMOMA. GICNO (GRUPPO ITALIANO COOPERATIVO NEURO-ONCOLOGIA) 14
Efficacy of endoscopic ultrasound-guided ablation with the hybridtherm probe in locally advanced or borderline resectable pancreatic cancer: A phase ii randomized controlled trial 14
Epidemiology and geographic distribution of BRCA1-2 and DNA Damage response genes pathogenic variants in pancreatic ductal adenocarcinoma patients 14
Justifying vein resection with pancreato-duodenectomy 13
Adjuvant Chemoradiation in Pancreatic Cancer: A Pooled Analysis in Elderly (≥75 years) Patients 13
Clinical signature and pathogenetic factors of diabetes associated with pancreas disease (T3cDM): a prospective observational study in surgical patients 13
A four-step method to centralize pancreatic surgery, accounting for volume, performance and access to care 13
A multicenter retrospective study of chemotherapy for recurrent intracranial ependymal tumors in adults by the Gruppo Italiano Cooperativo di Neuro-Oncologia 13
Weekly epirubicin as salvage therapy inpatient with gemcitabine-refractory pancreatic cancer 13
A randomized phase II trial of adjuvant chemotherapy with cisplatin, epirubicin, 5-fluorouracil, gemcitabine (PEFG regimen) or gemcitabine alone after curative resection for pancreatic cancer 13
Neoadjuvant chemoradiotherapy in patients with esopageal or esophageal gastric junction cancer 13
Adjuvant PEFG (Cisplatin, Epirubicin, 5-Fluorouracil, Gemcitabine) or Gemcitabine Followed by Chemoradiation in Pancreatic Cancer: A Randomized Phase II Trial 13
A polymorphism in the promoter is associated with EZH2 expression but not with outcome in advanced pancreatic cancer patients 13
Overall Survival With Adjuvant mFOLFIRINOX for Pancreatic Cancer 12
EUS-guided ablation with the HybridTherm Probe as second-line treatment in patients with locally advanced pancreatic ductal adenocarcinoma: A case-control study 12
A Comprehensive Characterization of Stemness in Cell Lines and Primary Cells of Pancreatic Ductal Adenocarcinoma 12
Diagnostic and therapeutic management of neuroendocrine lung tumors. A clinical study of 44 cases 12
(Ir)relevance of Metformin Treatment in Patients with Metastatic Pancreatic Cancer: An Open-Label, Randomized Phase II Trial 12
Randomized Phase II Trial on Primary Chemotherapy with High-Dose Methotrexate Alone or Associated with High-DoseCytarabine for Patients with Primary CNS Lymphoma (IELSG #20 Trial): Tolerability, Activity and Event-Free Survival Analysis 12
3D conformal radiotherapy significantly reduces toxicity of post-prostatectomy adjuvant or salvage irradiation 12
A randomized phase II trial of two different four-drug combinations in advanced pancreatic adenocarcinoma: cisplatin, capecitabine, gemcitabine plus either epirubicin or docetaxel 12
A phase II trial of second-line therapy with trabectedin in metastatic pancreatic adenocarcinoma 12
XELIRI or FOLFIRI as Salvage Therapy in Advanced Pancreatic Cancer 12
EUS-guided gallbladder drainage and subsequent peroral endoscopic cholecystolithotomy: A tool to reduce chemotherapy discontinuation in neoplastic patients? 11
The Impact of CT-Assessed Liver Steatosis on Postoperative Complications After Pancreaticoduodenectomy for Cancer 11
Ex-vivo investigation of radiofrequency ablation in pancreatic adenocarcinoma after neoadjuvant chemotherapy 11
Cyclophosphamide maintenance to extend combination chemotherapy-free interval in metastatic pancreatic ductal adenocarcinoma 11
MATILDE chemotherapy regimen for primary CNS lymphoma Results at a median follow-up of 12 years 11
Solitary clival plasmocytomas: Misleading clinical and radiological features of a rare pathology with a specific biological behaviour. 11
Efficacia e sicurezza dei sistemi totalmente impiantabili per accesso vascolare a lungo termine.Studio prospettico 11
Pexg (P : Cisplatin, E : Epirubicin, X : Capecitabine, G : Gemcitabine) versus PDXG (D : Docetaxel) regimen in advanced pancreatic cancer: A randomized phase II trial 11
Treatment opportunities and future perspectives for pancreatic cancer patients with germline BRCA1-2 pathogenic variants 11
Chemotherapy toxicity and activity in patients with pancreatic ductal adenocarcinoma and germline BRCA1-2 pathogenic variants (gBRCA1-2pv): a multicenter survey 11
APX005M, a CD40 monoclonal antibody, for patients with pancreatic adenocarcinoma 11
A phase II trial of PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) in advanced gallbladder, biliary tract, and ampulla of Vater adenocarcinoma, preliminary results 11
Evaluation of Minimal Important Difference and Responder Definition in the EORTC QLQ-PAN26 Module for Assessing Health-Related Quality of Life in Patients with Surgically Resected Pancreatic Adenocarcinoma 11
Communication, understanding and engagement of patients with pancreatic cancer at time of diagnosis 10
Chemotherapy in elderly patients with pancreatic cancer: Efficacy, feasibility and future perspectives 10
Regret affects the choice between neoadjuvant therapy and upfront surgery for potentially resectable pancreatic cancer 10
Pancreatic cancer: still a cold case? 10
Routine Molecular Profiling in Both Resectable and Unresectable Pancreatic Adenocarcinoma: Relevance of Cytologic Samples 10
Preoperative Chemotherapy Does Not Adversely Affect Pancreatic Structure and Short-Term Outcome after Pancreatectomy 10
Questions and answers in the management of primary central nervous system and ocular lymphomas 10
Gene expression analysis of embryonic pancreas development master regulators and terminal cell fate markers in resected pancreatic cancer: A correlation with clinical outcome 10
Hypofractionated image-guided IMRT in advanced pancreatic cancer with simultaneous integrated boost to infiltrated vessels concomitant with capecitabine: a phase I study 10
Gemcitabine versus cisplatin, epirubicin, fluorouracil, and gemcitabine in advanced pancreatic cancer: a randomised controlled multicentre phase III trial 10
Post-operative Intensity-Modulated hypofractionated Image-Guided Radiotherapy in cholangiocarcinoma 10
Systemic chemotherapy for advanced rare pancreatic histotype tumors: A retrospective multicenter analysis 10
Pancreatic Enzyme Replacement Therapy in Patients Undergoing First-Line Gemcitabine Plus nab-paclitaxel for Advanced Pancreatic Adenocarcinoma 10
Clinical outcomes and response to chemotherapy in a cohort of pancreatic cancer patients with germline variants of unknown significance (VUS) in BRCA1 and BRCA2 genes 9
Feasibility of therapeutic endoscopic ultrasound in the bridge-to-surgery scenario: The example of pancreatic adenocarcinoma 9
Salvage therapy with temozolomide in patients with aggressive or metastatic pituitary adenomas: experience in six cases. 9
Aberrant methylation in the promoter region of the reduced folate carrier gene is a potential mechanism of resistance to methotrexate in primary central nervous system lymphomas 9
Consolidation radiotherapy to bulky or semibulky lesions in the management of stage III-IV diffuse large B cell lymphomas 9
Feasibility and safety of EUS-guided cryothermal ablation in patients with locally advanced pancreatic cancer 9
Capecitabine with/without mitomycin C: results of a randomized phase II trial of second-line therapy in advanced biliary tract adenocarcinoma 9
Prognostic value of carbohydrate antigen (CA) 19-9 decrease in response to chemotherapy for advanced pancreatic adenocarcinoma (PA) 9
Le infezioni erpetiche nel paziente immunocompromesso 9
Survival following adjuvant PCV or temozolomide for anaplastic astrocytoma 9
Totale 1.455
Salva come PNG Salva come JPEG
Categoria #
all - tutte 64.508
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 64.508
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202028 2 2 0 13 0 0 10 0 0 1 0 0
2020/202123 0 0 0 1 6 8 7 1 0 0 0 0
2021/2022329 0 0 0 30 10 2 5 232 18 5 8 19
2022/20231.774 786 437 54 14 13 220 50 92 51 17 23 17
2023/2024871 53 52 88 93 84 132 26 86 23 35 56 143
2024/20257 7 0 0 0 0 0 0 0 0 0 0 0
Totale 3.044